Daniel Bauer

This early-stage trial is testing a one-time gene editing treatment for people with severe sickle cell disease or beta-thalassemia. Doctors take a patient's own blood stem cells, edit a specific gene to boost healthy fetal hemoglobin, and return the cells after chemotherapy. The …